US consumers need easier ADR reporting

Citing US citizen's frustration with television advertisments that sell the "good news" about prescription medicines but gloss over side effects, the Consumers Union says it is collecting 50,000 signatures on a petition to the Food and Drug Administration demanding that the agency makes it easier for patients to report problems with their medications.

The citizens petition requests the FDA to require that all TV ads for prescription and over-the-counter medications include a toll-free number and web address so the public can easily report adverse drug reactions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight